Literature DB >> 30539775

Congenital blindness is protective for schizophrenia and other psychotic illness. A whole-population study.

Vera A Morgan1, Melanie Clark2, Julie Crewe3, Giulietta Valuri4, David A Mackey3, Johanna C Badcock5, Assen Jablensky2.   

Abstract

Congenital/early blindness is reportedly protective against schizophrenia. Using a whole-population cohort of 467,945 children born in Western Australia between 1980 and 2001, we examined prevalence of schizophrenia and psychotic illness in individuals with congenital/early blindness. Overall, 1870 children developed schizophrenia (0.4%) while 9120 developed a psychotic illness (1.9%). None of the 66 children with cortical blindness developed schizophrenia or psychotic illness. Eight of the 613 children with peripheral blindness developed a psychotic illness other than schizophrenia and fewer had developed schizophrenia. Our results support findings from small case studies that congenital/early cortical but not peripheral blindness is protective against schizophrenia.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Congenital blindness; Cortical blindness; Peripheral blindness; Psychotic disorders; Schizophrenia

Mesh:

Year:  2018        PMID: 30539775     DOI: 10.1016/j.schres.2018.06.061

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

1.  Is Early Blindness Protective of Psychosis or Are We Turning a Blind Eye to the Lack of Statistical Power?

Authors:  Oskar Hougaard Jefsen; Liselotte Vogdrup Petersen; Toke Bek; Søren Dinesen Østergaard
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

2.  Blindness, Psychosis, and the Visual Construction of the World.

Authors:  Thomas A Pollak; Philip R Corlett
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

3.  Evidence From Imaging Resilience Genetics for a Protective Mechanism Against Schizophrenia in the Ventral Visual Pathway.

Authors:  Meike D Hettwer; Thomas M Lancaster; Eva Raspor; Peter K Hahn; Nina Roth Mota; Wolf Singer; Andreas Reif; David E J Linden; Robert A Bittner
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

4.  Oculomics in Schizophrenia Research.

Authors:  Steven M Silverstein; Brian P Keane; Philip R Corlett
Journal:  Schizophr Bull       Date:  2021-04-29       Impact factor: 9.306

Review 5.  Early-stage visual perception impairment in schizophrenia, bottom-up and back again.

Authors:  Petr Adámek; Veronika Langová; Jiří Horáček
Journal:  Schizophrenia (Heidelb)       Date:  2022-03-21

Review 6.  Neurobiological and behavioral mechanisms of circadian rhythm disruption in bipolar disorder: A critical multi-disciplinary literature review and agenda for future research from the ISBD task force on chronobiology.

Authors:  Michael J McCarthy; John F Gottlieb; Robert Gonzalez; Colleen A McClung; Lauren B Alloy; Sean Cain; Davide Dulcis; Bruno Etain; Benicio N Frey; Corrado Garbazza; Kyle D Ketchesin; Dominic Landgraf; Heon-Jeong Lee; Cynthia Marie-Claire; Robin Nusslock; Alessandra Porcu; Richard Porter; Philipp Ritter; Jan Scott; Daniel Smith; Holly A Swartz; Greg Murray
Journal:  Bipolar Disord       Date:  2021-12-10       Impact factor: 5.345

7.  Nonlinear functional network connectivity in resting functional magnetic resonance imaging data.

Authors:  Sara M Motlaghian; Aysenil Belger; Juan R Bustillo; Judith M Ford; Armin Iraji; Kelvin Lim; Daniel H Mathalon; Bryon A Mueller; Daniel O'Leary; Godfrey Pearlson; Steven G Potkin; Adrian Preda; Theo G M van Erp; Vince D Calhoun
Journal:  Hum Brain Mapp       Date:  2022-06-28       Impact factor: 5.399

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.